This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Wang DS , Patel A , Shukla S , Zhang YK , Wang YJ , Kathawala RJ , Robey RW , Zhang L , Yang DH , Talele TT , Bates SE , Ambudkar SV , Xu RH , Chen ZS
Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2
Oncotarget. 2014 Jun 30;5(12) :4529-42
PMID: 24980828 PMCID: PMC4147343
AbstractABCG2 is a potential biomarker causing multidrug resistance (MDR) in Non-Small Cell Lung Cancer (NSCLC). We conducted this study to investigate whether Icotinib, a small-molecule inhibitor of EGFR tyrosine kinase, could interact with ABCG2 transporter in NSCLC. Our results showed that Icotinib reversed ABCG2-mediated MDR by antagonizing the drug efflux function of ABCG2. Icotinib stimulated the ATPase activity in a concentration-dependent manner and inhibited the photolabeling of ABCG2 with [125I]-Iodoarylazidoprazosin, demonstrating that it interacts at the drug-binding pocket. Homology modeling predicted the binding conformation of Icotinib at Asn629 centroid-based grid of ABCG2. However, Icotinib at reversal concentration did not affect the expression levels of AKT and ABCG2. Furthermore, a combination of Icotinib and topotecan exhibited significant synergistic anticancer activity against NCI-H460/MX20 tumor xenografts. However, the inhibition of transport activity of ABCG2 was insufficient to overcome pemetrexed resistance in NCI-H460/MX20 cells, which was due to the co-upregulated thymidylate synthase (TS) and ABCG2 expression. This is the first report to show that the up-regulation of TS in ABCG2-overexpressing cell line NCI-H460/MX20 may play a role of resistance to pemetrexate. Our findings suggested different possible strategies of overcoming the resistance of topotecan and pemetrexed in the NSCLC patients.
Notes1949-2553 Wang, De-Shen Patel, Atish Shukla, Suneet Zhang, Yun-Kai Wang, Yi-Jun Kathawala, Rishil J Robey, Robert W Zhang, Li Yang, Dong-Hua Talele, Tanaji T Bates, Susan E Ambudkar, Suresh V Xu, Rui-Hua Chen, Zhe-Sheng Journal Article United States Oncotarget. 2014 Jun 30;5(12):4529-42.